| Identification |
| Name: | Iron,[[N,N',N''-[(3S,9Z,15S,21Z,27S,33Z)-7,19,31-tri(hydroxy-kO)-10,22,34-trimethyl-8,20,32-tri(oxo-kO)-2,14,26-trioxo-1,13,25-trioxa-7,19,31-triazacyclohexatriaconta-9,21,33-triene-3,15,27-triyl]tris[acetamidato]](3-)]- |
| Synonyms: | Iron,[[N2-acetyl-N5-hydroxy-N5-(5-hydroxy-3-methyl-1-oxo-2-pentenyl)-L-ornithinetrimol. lactonato](3-)]-, stereoisomer;1,13,25-Trioxa-7,19,31-triazacyclohexatriacontane, cyclic peptide deriv., ironcomplex; 1,13,25-Trioxa-7,19,31-triazacyclohexatriacontane, iron deriv.;L-Ornithine, N2-acetyl-N5-hydroxy-N5-(5-hydroxy-3-methyl-1-oxo-2-pentenyl)-,trimol. lactone, iron complex, stereoisomer; Fusigen,1-(N2-acetyl-N5-hydroxy-L-ornithine)-3-(N2-acetyl-N5-hydroxy-L-ornithine)-5-(N2-acetyl-N5-hydroxy-L-ornithine)-;Fusigen, N,N',N''-triacetyl-; N,N',N''-Triacetylfusarinine C;N,N',N''-Triacetylfusigen; NSC 295379; Triacetylfusarinine C |
| CAS: | 59200-35-0 |
| Molecular Formula: | C39H57 Fe N6 O15 |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C39H57N6O15.Fe/c1-25-13-19-58-37(52)31(40-28(4)46)11-8-17-44(56)35(50)23-27(3)15-21-60-39(54)33(42-30(6)48)12-9-18-45(57)36(51)24-26(2)14-20-59-38(53)32(41-29(5)47)10-7-16-43(55)34(49)22-25;/h22-24,31-33H,7-21H2,1-6H3,(H,40,46)(H,41,47)(H,42,48);/q-3;+3/b25-22-,26-24+,27-23?;/t31-,32-,33?;/m0./s1 |
| Molecular Structure: |
 |
| Properties |
| Safety Data |
| |
 |
